Illumina Settles With DOJ, Veterans To End Whistleblower Lawsuit

Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.

The agreement stems from a whistleblower lawsuit filed under the False Claims Act by Erica Lenore, who will receive $1.9 million as part of the settlement.

According to the U.S. Department of Justice, the allegations involved false claims submitted between February 2016 and September 2023 for Illumina's genomic sequencing systems, which included models like MiSeq Dx, NextSeq 500, and NextSeq 2000.

These systems operated using software known as Local Run Manager (LRM) and Universal Copy Service (UCS), which were allegedly affected by security flaws.

Also ...